Articles
-
3 days ago |
techtarget.com | Alivia Kaylor
Trump's tariff policy puts pharma supply chains at risk, increases global trade tensions and forces companies to face rising costs and compliance burdens.
-
1 week ago |
techtarget.com | Alivia Kaylor
Trump’s 10% import tariffs could disrupt U.S. medical device supply chains, raising costs and complicating compliance and production for MedTech manufacturers.
-
1 week ago |
techtarget.com | Alivia Kaylor
Reshoring doubts Trump claims that placing tariffs on pharmaceuticals will incentivize companies to bring manufacturing back to the U.S. However, industry experts question the feasibility and widely caution that pharmaceutical supply chains are too global, regulated and capital-intensive to realign quickly.
-
2 weeks ago |
techtarget.com | Alivia Kaylor
On April 10, 2025, Dexcom announced it had received FDA clearance for its Dexcom G7 15-Day continuous glucose monitoring system for use in adults aged 18 and older. The system extends wear time to 15.5 days and reports a mean absolute relative difference of 8.0%, making it one of the most durable and high-performing continuous glucose monitoring devices currently authorized in the U.S. market.
-
2 weeks ago |
techtarget.com | Alivia Kaylor
With semaglutide and tirzepatide shortages resolved, the FDA has set firm deadlines ending temporary compounding policies, marking a major shift as the GLP-1 market stabilizes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →